88 related articles for article (PubMed ID: 20843112)
1. Lack of p16 gene mutations in gastric cancers in Kashmir.
Bashir SA; Pandith AA; Yousuf A; Parveen N; Siddiqi MA; Muddassar S; Andrabi KI; Abdin MZ
Asian Pac J Cancer Prev; 2010; 11(2):339-42. PubMed ID: 20843112
[TBL] [Abstract][Full Text] [Related]
2. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer.
Ficorella C; Cannita K; Ricevuto E; Toniato E; Fusco C; Sinopoli NT; De Galitiis F; Di Rocco ZC; Porzio G; Frati L; Gulino A; Martinotti S; Marchetti P
Oncol Rep; 2003; 10(1):169-73. PubMed ID: 12469165
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer.
Günther T; Schneider-Stock R; Pross M; Manger T; Malfertheiner P; Lippert H; Roessner A
Pathol Res Pract; 1998; 194(12):809-13. PubMed ID: 9894245
[TBL] [Abstract][Full Text] [Related]
4. Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer.
He XS; Su Q; Chen ZC; He XT; Long ZF; Ling H; Zhang LR
World J Gastroenterol; 2001 Aug; 7(4):515-21. PubMed ID: 11819820
[TBL] [Abstract][Full Text] [Related]
5. [Analysis on point mutation of the CDKN2/p16 gene in lung cancer].
Su C; Ye Y; Wang D; Cao X; Li S; Shan X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):37-40. PubMed ID: 11836684
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
[TBL] [Abstract][Full Text] [Related]
7. Relationship between alterations of p16(INK4a) and p14(ARF) genes of CDKN2A locus and gastric carcinogenesis.
Tang S; Luo H; Yu J; Yang D; Shu J
Chin Med J (Engl); 2003 Jul; 116(7):1083-7. PubMed ID: 12890389
[TBL] [Abstract][Full Text] [Related]
8. [Study of deletion and mutation of p16 gene in primary hepatocellular carcinoma].
Qin Y; Chen J; Li B; Sun Z; Zuo F; Sun Z
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):492-4, 500. PubMed ID: 12528528
[TBL] [Abstract][Full Text] [Related]
9. Methylation and mutation analysis of p16 gene in gastric cancer.
Ding Y; Le XP; Zhang QX; Du P
World J Gastroenterol; 2003 Mar; 9(3):423-6. PubMed ID: 12632489
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.
Geddert H; Kiel S; Zotz RB; Zhang J; Willers R; Gabbert HE; Sarbia M
J Cancer Res Clin Oncol; 2005 Dec; 131(12):803-8. PubMed ID: 16163549
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16 gene and Rb protein in gastric carcinoma and their clinicopathological significance.
He XS; Rong YH; Su Q; Luo Q; He DM; Li YL; Chen Y
World J Gastroenterol; 2005 Apr; 11(15):2218-23. PubMed ID: 15818729
[TBL] [Abstract][Full Text] [Related]
12. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
13. The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma.
Tsai CH; Yang CC; Chou LS; Chou MY
J Oral Pathol Med; 2001 Oct; 30(9):527-31. PubMed ID: 11555154
[TBL] [Abstract][Full Text] [Related]
14. [A study on the inactivation of p16 genes and the expression of P16 protein in primary hepatocellular carcinomas].
Huang J; Shen W; Li B; Luo Y; Liao S; Zhang W; Cheng N
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):306-9. PubMed ID: 12545816
[TBL] [Abstract][Full Text] [Related]
15. p16 mutations/deletions are not frequent events in prostate cancer.
Tamimi Y; Bringuier PP; Smit F; van Bokhoven A; Debruyne FM; Schalken JA
Br J Cancer; 1996 Jul; 74(1):120-2. PubMed ID: 8679444
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the p16 gene in human neuroblastomas.
Castresana JS; Gómez L; García-Miguel P; Queizán A; Pestaña A
Mol Carcinog; 1997 Mar; 18(3):129-33. PubMed ID: 9115582
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p16 gene deletion and point mutation in breast carcinoma.
Quesnel B; Fenaux P; Philippe N; Fournier J; Bonneterre J; Preudhomme C; Peyrat JP
Br J Cancer; 1995 Aug; 72(2):351-3. PubMed ID: 7640217
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
19. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia.
Tsirigotis P; Pappa V; Labropoulos S; Papageorgiou S; Kontsioti F; Dervenoulas J; Papageorgiou E; Panani A; Mantzios G; Economopoulos T; Raptis S
Eur J Haematol; 2006 Mar; 76(3):230-6. PubMed ID: 16412137
[TBL] [Abstract][Full Text] [Related]
20. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
